Skip to main content
Erschienen in: International Journal of Clinical Pharmacy 5/2021

06.03.2021 | Research Article

Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study

verfasst von: Fei Yee Lee, Farida Islahudin, Mohd Makmor-Bakry, Hin-Seng Wong, Sunita Bavanandan

Erschienen in: International Journal of Clinical Pharmacy | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background Optimum antihypertensive drug effect in chronic kidney disease is important to mitigate disease progression. As frequent adjustments to antihypertensive drugs might lead to problems that may affect their effectiveness, the modifiable factors leading to frequent adjustments of antihypertensive drugs should be identified and addressed. Objective This study aims to identify the factors associated with frequent adjustments to antihypertensive drugs among chronic kidney disease patients receiving routine nephrology care. Setting Nephrology clinics at two Malaysian tertiary hospitals. Method This multi-centre, retrospective cohort study included adult patients under chronic kidney disease clinic follow-up. Demographic data, clinical information, laboratory data and medication characteristics from 2018 to 2020 were collected. Multiple logistic regression was used to identify the factors associated with frequent adjustments to antihypertensive drugs (≥ 1 per year). Main outcome measure Frequent adjustments to antihypertensive drugs. Results From 671 patients included in the study, 219 (32.6%) had frequent adjustments to antihypertensive drugs. Frequent adjustment to antihypertensive drugs was more likely to occur with follow-ups in multiple institutions (adjusted Odds Ratio [aOR] 1.244, 95% confidence interval [CI] 1.012, 1.530), use of traditional/complementary medicine (aOR 2.058, 95% CI 1.058, 4.001), poor medication adherence (aOR 1.563, 95% CI 1.037, 2.357), change in estimated glomerular filtration rate (aOR 0.970, 95% CI 0.951, 0.990), and albuminuria categories A2 (aOR 2.173, 95% CI 1.311, 3.603) and A3 (aOR 2.117, 95% CI 1.349, 3.322), after controlling for confounding factors. Conclusion This work highlights the importance of close monitoring of patients requiring initial adjustments to antihypertensive drugs. Antihypertensive drug adjustments may indicate events that could contribute to poorer outcomes in the future.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney Health for Everyone, Everywhere-from prevention to detection and equitable access to care. Nephrol Dial Transplant. 2020;35:367–74.CrossRef Li PK, Garcia-Garcia G, Lui SF, Andreoli S, Fung WW, Hradsky A, et al. Kidney Health for Everyone, Everywhere-from prevention to detection and equitable access to care. Nephrol Dial Transplant. 2020;35:367–74.CrossRef
2.
Zurück zum Zitat Kadir TNITA, Islahudin F, Abdullah MZ, Ibrahim N, Bing PK. Assessing individual medication adherence among chronic kidney disease patients: a multi-centered study. J Pharm Res Int. 2019;31(4):1–11. Kadir TNITA, Islahudin F, Abdullah MZ, Ibrahim N, Bing PK. Assessing individual medication adherence among chronic kidney disease patients: a multi-centered study. J Pharm Res Int. 2019;31(4):1–11.
3.
Zurück zum Zitat Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clin Kidney J. 2019;12:663–72.CrossRef Schmidt IM, Hübner S, Nadal J, Titze S, Schmid M, Bärthlein B, et al. Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study. Clin Kidney J. 2019;12:663–72.CrossRef
4.
Zurück zum Zitat Tangkiatkumjai M, Walker DM, Praditpornsilpa K, Boardman H. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol. 2017;21:504–12.CrossRef Tangkiatkumjai M, Walker DM, Praditpornsilpa K, Boardman H. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol. 2017;21:504–12.CrossRef
5.
Zurück zum Zitat Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol. 2018;84:2811–23.CrossRef Laville SM, Metzger M, Stengel B, Jacquelinet C, Combe C, Fouque D, et al. Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. Br J Clin Pharmacol. 2018;84:2811–23.CrossRef
6.
Zurück zum Zitat Ismail H, Abdul Manaf MR, Abdul Gafor AH, Mohamad Zaher ZM, Ibrahim AIN. Economic Burden of ESRD to the Malaysian Health Care System. Kidney Int Rep. 2019;4(9):1261–70.CrossRef Ismail H, Abdul Manaf MR, Abdul Gafor AH, Mohamad Zaher ZM, Ibrahim AIN. Economic Burden of ESRD to the Malaysian Health Care System. Kidney Int Rep. 2019;4(9):1261–70.CrossRef
7.
Zurück zum Zitat Whittaker CF, Miklich MA, Patel RS, Fink JC. Medication safety principles and practice in CKD. Clin J Am Soc Nephrol. 2018;13:1738–46.CrossRef Whittaker CF, Miklich MA, Patel RS, Fink JC. Medication safety principles and practice in CKD. Clin J Am Soc Nephrol. 2018;13:1738–46.CrossRef
8.
Zurück zum Zitat Kolandaivelu K, Leiden BB, O’Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35:3267–76.CrossRef Kolandaivelu K, Leiden BB, O’Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35:3267–76.CrossRef
9.
Zurück zum Zitat Paterson C, Britten N. A narrative review shows the unvalidated use of self-report questionnaires for individual medication as outcome measures. J Clin Epidemiol. 2005;58(10):967–73.CrossRef Paterson C, Britten N. A narrative review shows the unvalidated use of self-report questionnaires for individual medication as outcome measures. J Clin Epidemiol. 2005;58(10):967–73.CrossRef
10.
Zurück zum Zitat Barber N. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.CrossRef Barber N. Patients’ problems with new medication for chronic conditions. Qual Saf Health Care. 2004;13(3):172–5.CrossRef
11.
Zurück zum Zitat Ibrahim J, Hazzan AD, Mathew AT, Sakhiya V, Zhang M, Halinski C, et al. Medication discrepancies in late-stage chronic kidney disease. Clin Kidney J. 2017;11:507–12.CrossRef Ibrahim J, Hazzan AD, Mathew AT, Sakhiya V, Zhang M, Halinski C, et al. Medication discrepancies in late-stage chronic kidney disease. Clin Kidney J. 2017;11:507–12.CrossRef
12.
Zurück zum Zitat Alhawassi TM, Krass I, Pont LG. Antihypertensive-related adverse drug reactions among older hospitalized adults. Int J Clin Pharm. 2018;40:428–35.CrossRef Alhawassi TM, Krass I, Pont LG. Antihypertensive-related adverse drug reactions among older hospitalized adults. Int J Clin Pharm. 2018;40:428–35.CrossRef
13.
Zurück zum Zitat Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007;49:12–26.CrossRef Sarafidis PA, Khosla N, Bakris GL. Antihypertensive therapy in the presence of proteinuria. Am J Kidney Dis. 2007;49:12–26.CrossRef
14.
Zurück zum Zitat Griffin KA. Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension. 2017;70:687–94.CrossRef Griffin KA. Hypertensive kidney injury and the progression of chronic kidney disease. Hypertension. 2017;70:687–94.CrossRef
15.
Zurück zum Zitat Corp IBM. IBM SPSS Statistics for Windows. 23rd ed. Armonk, NY: IBM Corp; 2015. Corp IBM. IBM SPSS Statistics for Windows. 23rd ed. Armonk, NY: IBM Corp; 2015.
16.
Zurück zum Zitat Bujang MA, Sa’at N, Sidik T, Joo LC. Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data. Malays J Med Sci. 2018;25(4):122–30.PubMedPubMedCentral Bujang MA, Sa’at N, Sidik T, Joo LC. Sample size guidelines for logistic regression from observational studies with large population: emphasis on the accuracy between statistics and parameters based on real life clinical data. Malays J Med Sci. 2018;25(4):122–30.PubMedPubMedCentral
18.
Zurück zum Zitat KDIGO WGC. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2012(3):1–150. KDIGO WGC. KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;2012(3):1–150.
19.
Zurück zum Zitat WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2020. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2019. ISBN:978-82-8406-046-0 WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2020. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 2019. ISBN:978-82-8406-046-0
20.
Zurück zum Zitat Iacobucci D, Posavac SS, Kardes FR, Schneider MJ, Popovich DL. Toward a more nuanced understanding of the statistical properties of a median split. J Consum Psychol. 2015;25:652–65.CrossRef Iacobucci D, Posavac SS, Kardes FR, Schneider MJ, Popovich DL. Toward a more nuanced understanding of the statistical properties of a median split. J Consum Psychol. 2015;25:652–65.CrossRef
21.
Zurück zum Zitat Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705.CrossRef Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705.CrossRef
22.
Zurück zum Zitat Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32:541–8.CrossRef Schmitt KE, Edie CF, Laflam P, Simbartl LA, Thakar CV. Adherence to antihypertensive agents and blood pressure control in chronic kidney disease. Am J Nephrol. 2010;32:541–8.CrossRef
23.
Zurück zum Zitat Harrell Jr FE. Multivariable Modeling Strategies. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. Cham: Springer International Publishing; 2015. ISBN:978-3-319-19425-7. Harrell Jr FE. Multivariable Modeling Strategies. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis. Cham: Springer International Publishing; 2015. ISBN:978-3-319-19425-7.
24.
Zurück zum Zitat Hosmer DW J, Lemeshow S. Assessing the fit of the model. In: Hosmer DW J, Lemeshow S, editors. Applied Logistic Regression. Danvers: Wiley; 2000. p. 156–64. ISBN:0-471-35632-8. Hosmer DW J, Lemeshow S. Assessing the fit of the model. In: Hosmer DW J, Lemeshow S, editors. Applied Logistic Regression. Danvers: Wiley; 2000. p. 156–64. ISBN:0-471-35632-8.
26.
Zurück zum Zitat Chang AR, Lóser M, Malhotra R, Appel LJ. Blood pressure goals in patients with CKD. Clin J Am Soc Nephrol. 2019;14:161–9.CrossRef Chang AR, Lóser M, Malhotra R, Appel LJ. Blood pressure goals in patients with CKD. Clin J Am Soc Nephrol. 2019;14:161–9.CrossRef
27.
Zurück zum Zitat Sino CGM, Stuffken R, Heerdink ER, Schuurmans MJ, Souverein PC, Egberts TACG. The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC Pharmacol Toxicol. 2013;14(39). Sino CGM, Stuffken R, Heerdink ER, Schuurmans MJ, Souverein PC, Egberts TACG. The association between prescription change frequency, chronic disease score and hospital admissions: a case control study. BMC Pharmacol Toxicol. 2013;14(39).
28.
Zurück zum Zitat Islahudin F, Shahdan IA, Mohamad-Samuri S. Association between belief and attitude toward preference of complementary alternative medicine use. Patient Prefer Adherence. 2017;11:913–8.CrossRef Islahudin F, Shahdan IA, Mohamad-Samuri S. Association between belief and attitude toward preference of complementary alternative medicine use. Patient Prefer Adherence. 2017;11:913–8.CrossRef
29.
Zurück zum Zitat Dahl NV. Alternative Medicine and Nephrology Series Editor: Naomi V. Dahl: herbs and supplements in dialysis patients: panacea or poison? Semin Dial. 2001;14(3):186–92.CrossRef Dahl NV. Alternative Medicine and Nephrology Series Editor: Naomi V. Dahl: herbs and supplements in dialysis patients: panacea or poison? Semin Dial. 2001;14(3):186–92.CrossRef
30.
Zurück zum Zitat Muhammad Yusuf A, Abdul Gafor AH, Shamsul AS. The use of complementary and alternative medicine among Malaysian Chronic Kidney Disease Patients. Med Health. 2019;14(2):219–34.CrossRef Muhammad Yusuf A, Abdul Gafor AH, Shamsul AS. The use of complementary and alternative medicine among Malaysian Chronic Kidney Disease Patients. Med Health. 2019;14(2):219–34.CrossRef
31.
Zurück zum Zitat Cedillo-Couvert EA, Ricardo AC, Chen J, Cohan J, Fischer MJ, Krousel-Wood M, et al. Self-reported medication adherence and CKD progression. Kidney Int Rep. 2018;3(3):645–51.CrossRef Cedillo-Couvert EA, Ricardo AC, Chen J, Cohan J, Fischer MJ, Krousel-Wood M, et al. Self-reported medication adherence and CKD progression. Kidney Int Rep. 2018;3(3):645–51.CrossRef
32.
Zurück zum Zitat Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52:903–16.CrossRef Seng JJB, Tan JY, Yeam CT, Htay H, Foo WYM. Factors affecting medication adherence among pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis of literature. Int Urol Nephrol. 2020;52:903–16.CrossRef
33.
Zurück zum Zitat Ng YK, Shah NM, Loong LS, Pee LT, Hidzir SAM, Chong WW. Attitudes toward concordance and self-efficacy in decision making: a cross-sectional study on pharmacist-patient consultations. Patient Prefer Adherence. 2018;12:615–24.CrossRef Ng YK, Shah NM, Loong LS, Pee LT, Hidzir SAM, Chong WW. Attitudes toward concordance and self-efficacy in decision making: a cross-sectional study on pharmacist-patient consultations. Patient Prefer Adherence. 2018;12:615–24.CrossRef
34.
Zurück zum Zitat Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009;29:1433–40.CrossRef Pai AB, Boyd A, Depczynski J, Chavez IM, Khan N, Manley H. Reduced drug use and hospitalization rates in patients undergoing hemodialysis who received pharmaceutical care: a 2-year, randomized, controlled study. Pharmacotherapy. 2009;29:1433–40.CrossRef
35.
Zurück zum Zitat Siti ZM, Tahir A, Farah AI, Fazlin SM, Sondi S, Azman AH, et al. Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med. 2009;17(5–6):292–9.CrossRef Siti ZM, Tahir A, Farah AI, Fazlin SM, Sondi S, Azman AH, et al. Use of traditional and complementary medicine in Malaysia: a baseline study. Complement Ther Med. 2009;17(5–6):292–9.CrossRef
36.
Zurück zum Zitat Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdiscip Math. 2010;13:253–67.CrossRef Midi H, Sarkar SK, Rana S. Collinearity diagnostics of binary logistic regression model. J Interdiscip Math. 2010;13:253–67.CrossRef
Metadaten
Titel
Factors associated with the frequency of antihypertensive drug adjustments in chronic kidney disease patients: a multicentre, 2-year retrospective study
verfasst von
Fei Yee Lee
Farida Islahudin
Mohd Makmor-Bakry
Hin-Seng Wong
Sunita Bavanandan
Publikationsdatum
06.03.2021
Verlag
Springer International Publishing
Erschienen in
International Journal of Clinical Pharmacy / Ausgabe 5/2021
Print ISSN: 2210-7703
Elektronische ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-021-01252-z

Weitere Artikel der Ausgabe 5/2021

International Journal of Clinical Pharmacy 5/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Neu im Fachgebiet Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.